US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med
Medigus-Backed Polyrizon Develops Technology Potentially Effective Against Influenza Virus
Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial
Why Novavax Shares Down, Despite Positive Results from Flu/COVID-19 Vaccine Testing
Influenza Recent News
Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates
BioCryst Gains After FDA Nod For Expanded Use of RAPIVAB
CDC: 44 States Still Reporting High Flu Activity
Altimmune's Flu Shot Study: What You Need To Know
Altimmune Shares Volatile After Presentation of Positive Flu Vaccine Data at IDWeek
Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James
CDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths Rise
Analyst: When Americans Sneeze, Teladoc And Athenahealth Profit
Don't Bother Using FluMist; It Just Doesn't Work